Microbial Niche Mapping via Metabolic Interaction Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to reliably identify functional deviations from a healthy microbiome due to limitations in taxonomic analyses and gene-based predictions, particularly in understanding the genetic encoding and contextual expression of microbial functionalities, making it challenging to diagnose and treat microbiome-linked diseases like dysbiosis.

Innovation Solution

A niche mapping platform that focuses on the metabolic interactions of bacteria within specific habitats, using enrichment experiments to identify bacterial strains with competitive advantages under defined niche conditions, creating a microbiome niche map that describes the optimal conditions for bacterial growth and composition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If taxonomic analyses are used to identify microbiome composition, then species classification is achieved, but functional deviations from healthy microbiome cannot be reliably identified

Engineering Contradiction:
Improvefunctional deviation identificationVSAvoiddysbiosis diagnosis reliability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent transitions from taxonomic parameters (species identification) to functional parameters (metabolic activity, gene expression, protein production) to characterize microbiome states. This parameter change enables reliable identification of functional deviations by measuring actual metabolic outputs rather than just species presence, directly resolving the contradiction between measurement precision for functional deviations and reliability for dysbiosis diagnosis

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces metagenomic and metatranscriptomic analyses as intermediary methods that bridge taxonomy and function. These intermediaries capture genetic potential and actual gene expression, providing a reliable pathway from species identification to functional assessment, thereby enabling both accurate functional deviation detection and reliable dysbiosis diagnosis

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If gene-based functional analyses are used to predict microbial functionalities, then functional possibilities are described, but contextual expression and actual activities cannot be determined

Engineering Contradiction:
Improvefunctional prediction capabilityVSAvoidcontextual expression measurement
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent employs metatranscriptomic analysis to capture dynamic gene expression over time and under different conditions. This periodic sampling of transcriptional activity reveals contextual expression patterns that static gene catalogs cannot detect, enabling precise measurement of when and under what conditions specific functionalities are actually expressed

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The patent moves from static genomic parameters (gene presence) to dynamic transcriptomic and proteomic parameters (gene expression levels, protein abundance). This parameter transformation enables precise measurement of contextual expression by capturing the actual functional state of the microbiome under specific environmental conditions

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If limited isolated bacteria are used for computational predictions, then metabolic activity can be predicted, but the broader microbiome composition cannot be characterized

Engineering Contradiction:
Improvemetabolic activity predictionVSAvoidmicrobiome composition characterization
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent develops a multi-layered analytical framework that simultaneously handles both prediction and characterization functions. The system integrates metagenomic sequencing (for composition), metatranscriptomic analysis (for functional expression), and metabolomic profiling (for metabolic activity), creating a universal platform that performs multiple functions across the entire microbiome community rather than relying on limited isolated strains

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20230227885A1Microbial niche mapping
Publication Date: 2023.07.20 PHARMABIOME AG
  • US20230227885A1 patent drawing
  • US20230227885A1 patent drawing
  • US20230227885A1 patent drawing

AI summary

The invention concerns methods for mapping microbial niches and their uses.